| MPS | Mucopolysaccharidosis |
| MPSII | Mucopolysaccharidosis type II |
| IDS | Iduronate 2-sulfatase |
| NPs | nanoparticles |
| g7 | Gly-L-Phe-D-Thr-Gly-L-Phe-L-Leu-L-Ser(O-β-D-Glucose)-CONH2 |
| g7-NPs | Brain targeted NPs |
| g7-NPs-IDS | g7-NPs loaded with IDS enzyme |
| LSDs | Lysosomal storage disorders |
| GAG | Glycosaminoglycan |
| ERT | Enzyme replacement therapy |
| BBB | Blood-brain barrier |
| CNS | Central nervous system |
| PLGA | Poly(D,L-lactide-co-glycolide) |
| Ids-ko | Ids knockout |
| Wt | Wild-type |
| UT | Untreated |
| PVA | Polyvinyl alcohol |
| PBS | Phosphate buffer saline |
| FBS | Fetal bovine serum |
| NBT/BCIP | nitro-blue tetrazolium chloride/5-bromo-4-chloro-3′-indolyphosphate p-toluidine salt |